RARE DISEASERESEARCH ATLAS

ORPHA:684290

Hypertrophic olivary degeneration

medium confidenceDisorder

Also known as: HOD

Publications

477

85.3th percentile

Trials

0

Interventional, condition-specific

Researchers

1,013

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    477 matched papers (309 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

477

477 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

477 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

309 in the last 10 years · medium confidence · 85.3th percentile (publications denominator)

Phrase hits: 477 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,013

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Foerch C5 papers · 2022

    Department of Neurology, University Hospital Frankfurt, Goethe-University, 60528 Frankfurt am Main, Germany.

    Papers in Europe PMC
  2. 02
    Flanagan EP4 papers · 2025

    Department of Neurology (E.P.F.), Mayo Clinic, Rochester, Minnesota.

    Papers in Europe PMC
  3. 03
    Jain A4 papers · 2026

    All India Institute of Medical Sciences, Rae Bareli, Uttar Pradesh, India.

    Papers in Europe PMC
  4. 04
    Reis F4 papers · 2024

    Department of Radiology, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.

    Papers in Europe PMC
  5. 05
    Schaller-Paule MA4 papers · 2022

    Department of Neurology, University Hospital Frankfurt, Goethe-University, 60528 Frankfurt am Main, Germany.

    Papers in Europe PMC
  6. 06
    Arunachal G3 papers · 2025

    Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.

    Papers in Europe PMC
  7. 07
    Dubey D3 papers · 2025

    Neurology, Mayo Clinic, Rochester, Minnesota, USA Dubey.Divyanshu@mayo.edu.

    Papers in Europe PMC
  8. 08
    Elble RJ3 papers · 2026

    Southern Illinois Unbiversity, Carbondale, Illinois USA.

    Papers in Europe PMC
  9. 09
    Flemming KD3 papers · 2026

    Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

    Papers in Europe PMC
  10. 10
    Hattingen E3 papers · 2022

    Institute of Neuroradiology, University Hospital Frankfurt, Goethe-University, 60528 Frankfurt am Main, Germany.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

medium confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

General rare disease registries you may be eligible for

These studies enroll across many rare conditions. They are not counted as evidence that anyone is studying this specific disease.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Hypertrophic olivary degeneration"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Hypertrophic olivary degeneration"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: HOD

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T20:27:24.173Z